The changing patterns of chronic kidney disease: The need to develop strategies for prevention relevant to different regions and countries

被引:26
作者
Atkins, RC [1 ]
机构
[1] Monash Med Ctr, Dept Nephrol, Melbourne, Vic 3168, Australia
关键词
chronic kidney disease; prevention programs; hypertension; diabetes; cardiovascular disease;
D O I
10.1111/j.1523-1755.2005.09815.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic diseases are now in pandemic proportions and are the major cause of morbidity and mortality worldwide. Long-term predictions show that the burden will fall increasingly on developing countries. Type II diabetes is now the major global cause of chronic kidney disease. However, chronic kidney disease should not be viewed in isolation, because it is also a major risk factor for cardiovascular deaths. It is both a medical and economic imperative to introduce screening and management programs for chronic kidney disease, diabetes, hypertension, and cardiovascular disease worldwide but particularly in the emerging world. Such programs should be tailored to the needs of the individual country, involve local health providers, be assessable as to their efficacy, and become self-sufficient within 5 years.
引用
收藏
页码:S83 / S85
页数:3
相关论文
共 15 条
[1]   Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults [J].
Beaglehole, R ;
Yach, D .
LANCET, 2003, 362 (9387) :903-908
[2]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[3]   Prevalence of kidney damage in Australian adults: The AusDiab Kidney Study [J].
Chadban, SJ ;
Briganti, EM ;
Kerr, PG ;
Dunstan, DW ;
Welborn, TA ;
Zimmet, PZ ;
Atkins, RC .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07) :S131-S138
[4]   Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population [J].
Hillege, HL ;
Fidler, V ;
Diercks, GFH ;
van Gilst, WH ;
de Zeeuw, D ;
van Veldhuisen, DJ ;
Gans, ROB ;
Janssen, WMT ;
Grobbee, DE ;
de Jong, PE .
CIRCULATION, 2002, 106 (14) :1777-1782
[5]   Chronic kidney disease predicts cardiovascular disease [J].
Hostetter, TH .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1344-1346
[6]  
*INT DIAB FED, 2004, DIAB ATL
[7]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[8]  
Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37
[9]   ESRD patients in 2001: global overview of patients, treatment modalities and development trends [J].
Moeller, S ;
Gioberge, S ;
Brown, G .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (12) :2071-2076
[10]   Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. [J].
Tuomilehto, J ;
Lindström, J ;
Eriksson, JG ;
Valle, TT ;
Hamalainen, H ;
Ilanne-Parikka, P ;
Keinanen-Kiukaanniemi, S ;
Laakso, M ;
Louheranta, A ;
Rastas, M ;
Salminen, V ;
Uusitupa, M ;
Aunola, S ;
Cepaitis, Z ;
Moltchanov, V ;
Hakumaki, M ;
Mannelin, M ;
Martikkala, V ;
Sundvall, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (18) :1343-1350